Asthma therapy: How far have we come, why did we fail and where should we go next?

European Respiratory Journal

Volumn 33, Issue 1, 2009, Pages 11-20

  Janssen, L J ^a,b  

^a ST JOSEPH S HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Airway smooth muscle; Asthma; Ion channels; Myosin light chain; Receptors

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2 AMINOETHOXYDIPHENYLBORANE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACTIN; ANTIHISTAMINIC AGENT; APOCYNUM CANNABINUM EXTRACT; AZASPIRACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALPHOSTIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOPIAZONIC ACID; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FASUDIL; GENISTIN; HERBACEOUS AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLXANTHINE; MUSCARINIC RECEPTOR BLOCKING AGENT; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN PHOSPHATASE; NIFEDIPINE; OPIATE; PHOSPHODIESTERASE INHIBITOR; PLANT EXTRACT; SKF 36965; THAPSIGARGIN; THEOPHYLLINE; TYRPHOSTIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XESTOSPONGIN C;

AIRWAY OBSTRUCTION; ANTICHOLINERGIC EFFECT; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; DISEASE EXACERBATION; DRUG TARGETING; EXCITATION CONTRACTION COUPLING; HUMAN; MEDICINAL PLANT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; TOBACCO;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; HUMANS; MUSCLE, SMOOTH; SIGNAL TRANSDUCTION;

EID: 58849103001     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00068508     Document Type: Review

References (76)

1. Solway J, Forsythe SM, Halayko AJ, Vieira JE, Hershenson MB, Camoretti-Mercado B. Transcriptional regulation of smooth muscle contractile apparatus expression. Am J Respir Crit Care Med 1998; 158: S100-S108.
2. Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1067-L1082.
3. Janssen LJ, Catalli A, Helli P. The pulmonary biology of isoprostanes. Antioxid Redox Signal 2005; 7: 244-255.
4. Janssen LJ, Premji M, Netherton S, et al. Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle. J Pharmacol Exp Ther 2000; 295: 506-511.
5. Barnes PJ. Clinical studies with calcium antagonists in asthma. Br J Clin Pharmacol 1985; 20: Suppl. 2, 289S-298S.
6. Fish JE. Calcium channel antagonists in the treatment of asthma. J Asthma 1984; 21: 407-418.
7. Gordon EH, Wong SC, Klaustermeyer WB. Comparison of nifedipine with a new calcium channel blocker, flordipine, in exercise-induced asthma. J Asthma 1987; 24: 261-265.
8. Hoppe M, Harman E, Hendeles L. The effect of inhaled gallopamil, a potent calcium channel blocker, on the late-phase response in subjects with allergic asthma. J Allergy Clin Immunol 1992; 89: 688-695.
9. Middleton E Jr. The treatment of asthma - beyond bronchodilators. N Engl Reg Allergy Proc 1985; 6: 235-237.
10. Riska H, Stenius-Aaniala B, Arvi AR. Comparison of the efficacy of an ACE-inhibitor and a calcium channel blocker in hypertensive asthmatics. A preliminiary report. Postgrad Med J 1986; 62: Suppl. 1, 52-53.
11. Sly PD, Olinsky A, Landau LI. Does nifedipine affect the diurnal variation of asthma in children? Pediatr Pulmonol 1986; 2: 206-210.
12. Trian T, Benard G, Begueret H, et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J Exp Med 2007; 204: 3173-3181.
13. Cook NS, Chapman ID. Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma. Cardiovasc Drugs Ther 1993; 7: Suppl. 3, 555-563.
14. Faurschou P, Mikkelsen KL, Steffensen I, Franke B. The lack of bronchodilator effect and the short-term safety of cumulative single doses of an inhaled potassium channel opener (bimakalim) in adult patients with mild to moderate bronchial asthma. Pulm Pharmacol 1994; 7: 293-297.
15. Kidney JC, Fuller RW, Worsdell YM, Lavender EA, Chung KF, Barnes PJ. Effect of an oral potassium channel activator, BRL 38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol. Thorax 1993; 48: 130-133.
16. Small RC, Berry JL, Burka JF, et al. Potassium channel activators and bronchial asthma. Clin Exp Allergy 1992; 22: 11-18.
17. 2+ regulation in airway smooth muscle contraction: do the data contradict dogma? Am J Physiol Lung Cell Mol Physiol 2002; 282: L1161-L1178.
18. Stephens NL. Airway smooth muscle. Lung 2001; 179: 333-373.
19. Tolloczko B, Turkewitsch P, Choudry S, Bisotto S, Fixman ED, Martin JG. Src modulates serotonin-induced calcium signaling by regulating phosphatidylinositol 4,5-bisphosphate. Am J Physiol Lung Cell Mol Physiol 2002; 282: L1305-L1313.
20. Mitchell HW, Sparrow MP. The relevance of pharmacological dose-response curves to airway narrowing. Trends Pharmacol Sci 1989; 10: 488-491.
21. 2. Am J Physiol Lung Cell Mol Physiol 2004; 287: L1035-L1041.
22. 2+-handling and Rho/ROCK signaling. Am J Physiol Lung Cell Mol Physiol 2006; 291: 1177-1184.
23. Gerthoffer WT. Agonist synergism in airway smooth muscle contraction. J Pharmacol Exp Ther 1996; 278: 800-807.
24. Oguma T, Ito S, Kondo M, et al. Roles of P2X receptors and Ca2+ sensitization in extracellular adenosine triphosphate-induced hyperresponsiveness in airway smooth muscle. Clin Exp Allergy 2007; 37: 893-900.
25. 2+ signaling: mechanisms and physiological roles. Am J Physiol 1995; 269: G173-G185.
26. 2+ signals are reshaped during propagation to subcellular regions. Biophys J 2001; 81: 57-65.
27. Davis JP, Tikunova SB, Walsh MP, Johnson JD. Characterizing the response of calcium signal transducers to generated calcium transients. Biochemistry 1999; 38: 4235-4244.
28. Berridge MJ. The AM and FM of calcium signalling. Nature 1997; 386: 759-760.
29. 2+ channels. Circ Res 2000; 86: 760-767.
30. Putney JW Jr. Calcium signaling: up, down, up, down...-what's the point? Science 1998; 279: 191-192.
31. Berridge MJ, Bootman MD, Lipp P. Calcium - a life and death signal. Nature 1998; 395: 645-648.
32. 2+ oscillations. Science 1998; 279: 227-230.
33. 2+ oscillations. Bioessays 1998; 20: 607-610.
34. Tompa P, Toth-Boconadi R, Friedrich P. Frequency decoding of fast calcium oscillations by calpain. Cell Calcium 2001; 29: 161-170.
35. 2+ signalling between sarco-endoplasmic reticulum and mitochondria. J Physiol 2000; 529: 69-81.
36. 3 receptor. Respir Res 2006; 7: 34.
37. Perez JF, Sanderson MJ. The frequency of calcium oscillations induced by 5-HT, ACH, and KCl determine the contraction of smooth muscle cells of intrapulmonary bronchioles. J Gen Physiol 2005; 125: 535-553.
38. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998; 392: 933-936.
39. 2+ spike frequency can optimize gene expression. Nature 1998; 392: 936-941.
40. Bergner A, Sanderson MJ. Acetylcholine-induced calcium signaling and contraction of airway smooth muscle cells in lung slices. J Gen Physiol 2002; 119: 187-198.
41. 2+ signaling in lung slices from different mouse strains. J Appl Physiol 2003; 95: 1325-1332.
42. 2+ handling in airway smooth muscle. Eur Respir J 2007; 30: 1400-1419.
43. Hirota SA, Janssen LJ. Sodium and asthma: something borrowed, something new? Am J Physiol Lung Cell Mol Physiol 2007; 293: L1369-L1373.
44. 2+ store in human and bovine airway smooth muscle. Eur Respir J 2008; 32: 275-284.
45. 2+ exchange. Eur Respir J 2007; 30: 269-278.
46. 2+ store in tracheal myocytes as indicated by ACh-evoked currents and contraction. Am J Physiol 1993; 265: C877-C886.
47. Fleischmann BK, Wang YX, Kotlikoff MI. Muscarinic activation and calcium permeation of nonselective cation currents in airway myocytes. Am J Physiol 1997; 272: C341-C349.
48. o requirements. Am J Physiol 1997; 273: C500-C508.
49. Janssen LJ, Sims SM. Acetylcholine activates non-selective cation and chloride conductances in canine and guinea-pig tracheal myocytes. J Physiol 1992; 453: 197-218.
50. 2+ mobilization. Am J Physiol Lung Cell Mol Physiol 2007; 292: L438-L447.
51. Gerthoffer WT, Gunst SJ. Invited review: focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle. J Appl Physiol 2001; 91: 963-972.
52. Janssen LJ, Wattie J, Lu-Chao H, Tazzeo T. Muscarinic excitation-contraction coupling mechanisms in tracheal and bronchial smooth muscles. J Appl Physiol 2001; 91: 1142-1151.
53. Abe MK, Chao TS, Solway J, Rosner MR, Hershenson MB. Hydrogen peroxide stimulates mitogen-activated protein kinase in bovine tracheal myocytes: implications for human airway disease. Am J Respir Cell Mol Biol 1994; 11: 577-585.
54. Conway AM, Rakhit S, Pyne S, Pyne NJ. Platelet-derived-growth-factor stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle: role of pertussis-toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase. Biochem J 1999; 337: 171-177.
55. Hirshman CA, Zhu D, Pertel T, Panettieri RA, Emala CW. Isoproterenol induces actin depolymerization in human airway smooth muscle cells via activation of an Src kinase and GS. Am J Physiol Lung Cell Mol Physiol 2005; 288: L924-L931.
56. Krymskaya VP, Goncharova EA, Ammit AJ, et al. Src is necessary and sufficient for human airway smooth muscle cell proliferation and migration. FASEB J 2005; 19: 428-430.
57. Krymskaya VP, Orsini MJ, Eszterhas AJ, et al. Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. Am J Respir Cell Mol Biol 2000; 23: 546-554.
58. Lew DB, Dempsey BK, Zhao Y, Muthalif M, Fatima S, Malik KU. β-hexosaminidase-induced activation of p44/42 mitogen-activated protein kinase is dependent on p21Ras and protein kinase C and mediates bovine airway smooth-muscle proliferation. Am J Respir Cell Mol Biol 1999; 21: 111-118.
59. Page K, Li J, Hodge JA, et al. Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J Biol Chem 1999; 274: 22065-22071.
60. Pertel T, Zhu D, Panettieri RA, Yamaguchi N, Emala CW, Hirshman CA. Expression and muscarinic receptor coupling of Lyn kinase in cultured human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006; 290: L492-L500.
61. Porcelli AM, Ghelli A, Hrelia S, Rugolo M. Phospholipase D stimulation is required for sphingosine-1-phosphate activation of actin stress fibre assembly in human airway epithelial cells. Cell Signal 2002; 14: 75-81.
62. Rakhit S, Conway AM, Tate R, Bower T, Pyne NJ, Pyne S. Sphingosine 1-phosphate stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle. Role of endothelial differentiation gene 1, c-Src tyrosine kinase and phosphoinositide 3- kinase. Biochem J 1999; 338: 643-649.
63. Rakhit S, Pyne S, Pyne NJ. The platelet-derived growth factor receptor stimulation of p42/p44 mitogen-activated protein kinase in airway smooth muscle involves a G-protein-mediated tyrosine phosphorylation of Gab1. Mol Pharmacol 2000; 58: 413-420.
64. Simon AR, Takahashi S, Severgnini M, Fanburg BL, Cochran BH. Role of the JAK-STAT pathway in PDGF-stimulated proliferation of human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2002; 282: L1296-L1304.
65. Smith PG, Garcia R, Kogerman L. Mechanical strain increases protein tyrosine phosphorylation in airway smooth muscle cells. Exp Cell Res 1998; 239: 353-360.
66. Tolloczko B, Tao FC, Zacour ME, Martin JG. Tyrosine kinase-dependent calcium signaling in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000; 278: L1138-L1145.
67. Zacour ME, Tolloczko B, Martin JG. Calcium and growth responses of hyperresponsive airway smooth muscle to different isoforms of platelet-derived growth factor (PDGF). Can J Physiol Pharmacol 2000; 78: 867-873.
68. 2+-insensitive contraction and paxillin tyrosine phosphorylation in smooth muscle. Am J Physiol Cell Physiol 2000; 279: C308-C318.
69. Tang D, Mehta D, Gunst SJ. Mechanosensitive tyrosine phosphorylation of paxillin and focal adhesion kinase in tracheal smooth muscle. Am J Physiol 1999; 276: C250-C258.
70. Tang DD, Wu MF, Opazo Saez AM, Gunst SJ. The focal adhesion protein paxillin regulates contraction in canine tracheal smooth muscle. J Physiol 2002; 542: 501-513.
71. Wang Z, Pavalko FM, Gunst SJ. Tyrosine phosphorylation of the dense plaque protein paxillin is regulated during smooth muscle contraction. Am J Physiol 1996; 271: C1594-C1602.
72. Cox PG, Miller J, Mitzner W, Leff AR. Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations. Eur Respir J 2004; 24: 659-663.
73. Danek CJ, Lombard CM, Dungworth DL, et al. Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. J Appl Physiol 2004; 97: 1946-1953.
74. Cox G, Thomson NC, Rubin AS, et al. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007; 356: 1327-1337.
75. Pavord ID, Cox G, Thomson NC, et al. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007; 176: 1185-1191.
76. Trian T, Benard G, Begueret H, et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J Exp Med 2007; 204: 3173-3181.